Emtri Tablet

Emtri Tablet is a nucleoside analogue. It is used in combination with other medications to treat HIV infection. It functions by interfering with the growth of the HIV infection.

On using this medication you may experience side effects such as nausea, joint pain, difficulty sleeping, diarrhea, cough, dizziness, swelling of the mouth, headache, reduced appetite, weakness, vomiting, darkening of the urine, numbness, mental/ mood disorders, ear pain, itchiness, sore throat and chest pain. If your reactions persist or worsen over time seek the help of your health care provider right away.

Before using this medication tell your doctor if: you are allergic to any ingredient contained within Emtri Tablet, you are taking any other medications especially emtricitabine and zalcitabine, you have enlarged liver/ high levels of lactic acid/ abnormal liver functioning/ muscle problems/ kidney problems/ lactic acidosis/ nerve disorder/ pancreas problem, you are overweight, you are pregnant or are planning to become pregnant or are nursing a baby.

The dosage for this medication should be based on your medical history and current condition. The usual dose in adults for HIV infection is about 150 mg twice daily or 300 mg once daily.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a HIV Specialist before using this medicine.

• Hiv Infection

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a HIV Specialist before using this medicine.

• Fatigue

• Headache

• Nausea

• Dizziness

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a HIV Specialist before using this medicine.

• Is It safe with alcohol?

  Interaction with alcohol is unknown. Please consult your doctor.

• Are there any pregnancy warnings?

  Lamivir s 150mg/60mg tablet may be unsafe to use during pregnancy.
  Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.

• Are there any breast-feeding warnings?

  Unknown. Human and animal studies are not available. Please consult your doctor.

• Is it safe to drive while on this medicine?

  Patients may experience dizziness and/or somnolence, and they should avoid driving or operating machinery.

• Does this affect kidney function?

  Caution to be advised in patients with moderate to severe impaired renal function.
  Dose adjustment is required in patients with underlined renal diseases. Please consult your doctor.

• Does this affect liver function?

  There is no data available. Please consult doctor before consuming the drug.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a HIV Specialist before using this medicine.

Emtri Tablet is a class of HIV nucleoside reverse transcriptase inhibitor (NRTIs) that blocks the HIV enzyme known as reverse transcriptase. It can be used for treating both HIV 1 and HIV 2 as well as hepatitis B (HBV) where stops DNA synthesis. However, Emtri Tablet is used in combination with other drugs to treat these diseases.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a HIV Specialist before using this medicine.

• Nevirapine-Drug Information Portal [Internet].druginfo.nlm.nih.gov 2022 [Cited 15 June 2022].Available from:

  https://druginfo.nlm.nih.gov/drugportal/name/nevirapine

• Nevirapine-DrugBank Online [Internet].go.drugbank.com 2022 [Cited 15 June 2022].Available from:

  https://go.drugbank.com/drugs/DB00238

• Lamivudine tablet,solution-DailyMed [Internet].dailymed.nlm.nih.gov 2022 [Cited 15 June 2022].Available from:

  https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=lamivudine